Published: Jeffrey Cummings

Dr. Jeffery Cummings (Brain Health) and other members of a joint European Union/United States Task Force recently published, “The Future of Anti-Amyloid Trials,” in the Journal of Prevention and Alzheimer’s Disease. The authors analyze the impact of multiple clinical trials that recently ended for a variety of reasons on the Alzheimer's disease clinical research enterprise. The task force concludes the study of amyloid proteins, while complex, remains a worthwhile undertaking and should not be the only target of clinical trials.They offer several recommendations in the trial design to optimize the potential benefits and reduce potential risks to participants as much as possible.

People in the News

People | June 5, 2020
How a classroom assignment led UNLV alumna Jessica Walters Murrey to a career as a social change communication expert.
Portrait of Dr. Daniel Diaz wearing blue scrubs. Diaz is playing a key role in day-to-day operations at UNLV Medicine's COVID-19 curbside test operation
People | June 1, 2020
A spate of childhood sports injuries first led Diaz to medical school and now to a sports medicine fellowship at UNLV.
UNLV student with engineering building in background
People | May 28, 2020
Engineer’s research on improved flood control for Las Vegas led to a flood of research publications and a bright future.